Impact of thymidylate synthase protein expression on efficacy of chemotherapy in advanced lung cancer patients

about

Prognostic significance of thymidylate synthase in postoperative non-small cell lung cancer patients

P2860

Q33944623-4BE9782A-BEE8-4DB3-9377-8E3B9FDE747B

P2860

Impact of thymidylate synthase protein expression on efficacy of chemotherapy in advanced lung cancer patients

Item

http://www.wikidata.org/entity/Q41879278

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Impact of thymidylate synthase ...... advanced lung cancer patients

@en

type

Item

label

Impact of thymidylate synthase ...... advanced lung cancer patients

@en

prefLabel

Impact of thymidylate synthase ...... advanced lung cancer patients

@en

P1476

Impact of thymidylate synthase ...... advanced lung cancer patients

@en

P2093

Noriaki Takahashi

http://www.w3.org/2001/XMLSchema#string

Shu Hashimoto

http://www.w3.org/2001/XMLSchema#string

Tetsuo Shimizu

http://www.w3.org/2001/XMLSchema#string

Yoshiko Nakagawa

http://www.w3.org/2001/XMLSchema#string

P2860

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

Thymidylate synthase and dihydrofolate reductase expression in non-small cell lung carcinoma: the association with treatment efficacy of pemetrexed.

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

Antisense down-regulation of thymidylate synthase to suppress growth and enhance cytotoxicity of 5-FUdR, 5-FU and Tomudex in HeLa cells

Phase III trial comparing oral S-1 plus carboplatin with paclitaxel plus carboplatin in chemotherapy-naïve patients with advanced non-small-cell lung cancer: results of a west Japan oncology group study.

Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy.

DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy.

Thymidylate synthase in situ protein expression and survival in stage I nonsmall-cell lung cancer.

ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapy.

P304

411-417

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/MCO.2013.94

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-03-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24649184

http://www.w3.org/2001/XMLSchema#string

P932

3916162

http://www.w3.org/2001/XMLSchema#string

Impact of thymidylate synthase protein expression on efficacy of chemotherapy in advanced lung cancer patients

about

P2860

P2860

Impact of thymidylate synthase protein expression on efficacy of chemotherapy in advanced lung cancer patients

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932